Radiation therapy regulates TCF-1 to maintain CD8+T cell stemness and promotes anti-tumor immunotherapy

Int Immunopharmacol. 2022 Jun:107:108646. doi: 10.1016/j.intimp.2022.108646. Epub 2022 Mar 4.

Abstract

Radiotherapy is a very effective cancer treatment, mainly through inducing DNA damage of cancer cells. Meanwhile, there is evidence that irradiation can also mobilize tumor-specific immunity, and recent investigations demonstrate that the efficiency of local high-dose radiotherapy is attributable to the presence of CD8+T cells. Here, we observed that high-dose radiation remarkably increased the enrichment of stem cell-like CD8+T cells. Moreover, cGAS/STING signaling augmented stem cell-like CD8+T cells and T stem-like central memory CD8+T cells in a mice tumor model after radiation. These findings raise our understanding of stem cell-like CD8+T cells after radiation stimulation and improve radiation therapy by driving the cGAS/STING signaling pathway for cancer multimodality therapy.

Keywords: Radiotherapy; Stem CD8+T; TCF-1; TME; cGAS/STING.

Publication types

  • Review

MeSH terms

  • Animals
  • CD8-Positive T-Lymphocytes
  • Immunotherapy
  • Membrane Proteins* / metabolism
  • Mice
  • Neoplasms* / drug therapy
  • Neoplasms* / radiotherapy
  • Nucleotidyltransferases / metabolism

Substances

  • Membrane Proteins
  • Nucleotidyltransferases